Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Myth #4: GLP-1 agonists are only for diabetics There is a widespread belief that GLP-1 agonists are exclusively for people with diabetes, leading to confusion about their use in weight loss for non-diabetic individuals
doi:10.3803/EnM.2024.1942 Lilly Investor Relations, News Release: Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine, May 11, 2025
Aetna Medicare plans and most state Medicaid plans wont cover Contrave or other weight-loss drugs, so whether you get coverage depends on which Aetna plan you have and whether your healthcare provider can document why Contrave is right for you
Bhattacharyya S, et al
Athletes managing a hamstring strain, a grade II calf tear, or chronic muscle tension patterns that are limiting training load are a common profile in our Miami practice
